Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 54 for “"Cancer Relapse"”.
-
Timely detection of cancer relapse. Routine follow-up in patients treated for ovarian and breast cancer
Radboud Universiteit Nijmegen, 22 januari 2013
-
Therapy Induced Senescent Tumor Cells Increase Cancer Stemness
… senescence induced by doxorubicin increases cancer cell stemness in human breast cancer. Senescence associated β-galactosidase assay and quantitative polymerase chain reaction analysis revealed BT474, a breast cancer cell line, showed senescence phenotype after treatment of doxorubicin …
-
Μελέτη των μικρομεταστάσεων στους βουβωνικούς λεμφαδένες ασθενών με καρκίνωμα αιδοίου και εκτίμηση της προγνωστικής σημασίας τους στην πορεία της νόσου
… metastases are a major determinant of vulvar cancer relapse. To date the impact of micrometastases of inguinal nodes on local recurrence rates of patients with vulvar cancer remains unknown. The purpose of the present retrospective study is to evaluate the rates of micrometastases in a series …
-
CELL-BASED CANCER IMMUNOTHERAPY: FROM ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY TO DENDRITIC CELLS THERAPEUTIC VACCINATION
In recent years, cancer immunotherapy has been shown as a promising cancer treatment strategy for cancer treatment. Antibody-dependent cellular cytotoxicity (ADCC) uses tumour-antigen specific antibodies to identify target cells before the infusion of effector cells to elicit anti-tumour effects. …
-
Enhancing the potency and water solubility of the sesquiterpene lactone parthenolide
… leukemia (AML) lack the ability to target cancer stem cells, one of the central reasons for cancer relapse. The natural product parthenolide is able to ablate the cancer stem cell population within tumors, which is paramount to it currently being developed as a clinical candidate. …
-
Investigating the impact of novel ER and HER2 mutations on resistance to ER-targeting therapies in metastatic breast cancer
The majority of breast cancer cases are dependent on estrogen signaling, which is why endocrine therapy, which targets estrogen receptor (ER) signaling, is the mainstay of therapy for patients with hormone receptor positive breast cancer. Despite the initial success of treatment, over time, most …
-
A Novel NGS Assay to Detect Any KMT2A Fusion Transcript at Low Levels
… disease (MRD) detection is associated with cancer relapse. Leukemias with rearrangement of the lysine methyltransferase 2 A gene (KMT2Ar) have an adverse prognosis with more than 80 possible fusion partner genes (FPG) identified. With the advent of effective targeted therapies for KMT2Ar …
-
Ο ρόλος των οδών μεταγωγής σήματος Hedgehog και Notch στον καρκίνο του παχέος εντέρου
Early-stage colorectal cancer (CRC) carries a wide range of survival probabilities. Despite the existence of well established prognostic factors and biomarkers survival estimation remains inaccurate. A possible reason for treatment failure and cancer relapse is considered the existence of cancer …
-
Η προγνωστική σημασία των δεικτών: ειδικό προστατικό αντιγόνο (PSA), μεταλλαγμένη πρωτεϊνη p53, οιστρογονικοί υποδοχείς (ER) και προγεστερονικοί υποδοχείς (PgR) στον καρκίνο του μαστού (κλινικοεργαστηριακή μελέτη)
… WITH ACCURACY THE OUTCOME FOR EACH BREAST CANCER PATIENT. IN RECENT YEARS, PROGRESS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY HAD ALLOWED THE DETERMINATION OF VARIOUS PROTEINS WHO WERE STUDIED FOR THEIR PROGNOSTIC SIGNIFICANCE IN BREAST CANCER PATIENTS. PROSTATE SPECIFIC ANTIGEN (PSA) WHICH WAS …
-
Aptamers and Peptides: Finding and Guiding CAR T Cells for Better Cancer Care
… (CAR) T-cell therapy has prompted a new age of cancer treatments, in which a patient’s T cells are genetically programmed with a cancer-targeting receptor ex vivo and reinfused for immune-mediated clearance of the tumor. However, despite some success in treating CD19+ B-cell malignancies in …
-
Investigating longitudinal evolution of liquid cancers using computational and mathematical models
Cancer can result from a series of driver mutations, alterations in the genome sequence that confer a fitness advantage to cells containing them, resulting in their net proliferation. Mutations that have a neutral fitness effect ("passenger mutations") also accumulate in cancer cells, contributing …
-
Cistektomijos vaidmuo gerybinių šlapimo pūslės susirgimų gydyme. Klinikinio atvejo aprašymas ir literatūros apžvalga /
… Cystectomy is commonly used for bladder cancer. However, the use of this method is little known for benign diseases and appears rarely in clinical practice. The aim of this thesis is to present a rare case of cystectomy due to benign disease and review the place of cystectomy in the …
-
Depletion of Dormant Hormone-Sensitive Breast Cancer Cells Using HDAC Inhibitors
… for estrogen receptor-positive (ER+) breast cancer, effectively halting tumor growth. However, a subset of cells persists in a cytostatic, dormant-like state, evading detection and treatment. These cytostatic persisters (CSPs) pose a significant risk of late recurrence, often years after …
-
Metastatic Breast Cancer: Biomolecular Characterization and Targeted Therapy
… a major challenge in the clinical management of cancer, because most cancer-related deaths are attributed to disseminated disease rather than the primary tumor. Despite the significant advances in the prediction of prognosis, and therapeutic management of primary breast cancers, coupled with the …
-
Mitochondria targeting metallopharmaceuticals for eradicating cancer stem cells
Cancer relapse is thought to be linked to the existence of a subpopulation of cancer cells in solid tumours and different leukaemia called cancer stem cells (CSCs). It is now widely accepted that in order to provide a long term, therapeutic effect, cancer treatments must be able to remove the whole …
-
Adhesion signature based enrichment of tumor initiating cells
In spite of major therapeutic advances, cancer relapse and low rates of patient response to cancer therapeutics persist. This failure is due in part to a small subpopulation of tumor initiating cells (TICs) with stem cell-like properties that are responsible for the growth of the tumor and the …
-
Exploring Targets of Allogeneic T cell Activation in Mouse Models of GvHD
… to mount immune responses against any residual cancer cells. However, alloreactivity towards the mismatched minor and major histocompatibility antigens the patient's healthy tissues leads to graft vs host disease (GvHD). This process is also mediated by Macrophages, Dendritic cells, B cells. …
-
THE EXTRACELLULAR MATRIX PROMOTES A STEMNESS PHENOTYPE IN BREAST CANCER CELLS VIA AN FGFR-RELATED SIGNALING CASCADE
Breast cancer is one of the leading causes of death among women worldwide. Nearly 40% of breast cancer patients experience recurrence. The leading theory to explain cancer relapse is the existence of cancer stem cells (CSCs) which can differentiate and self-renew within tumors. CSCs can sustain …
-
ENGINEERING BIOMIMETIC TUMOR MICROENVIRONMENTS WITH CONTROLLABLE STROMAL TOPOGRAPHY FOR STUDYING CANCER CELL DISSEMINATION
… resulting from unrestrained dissemination of cancer cells is the primary cause of cancer death. Disseminated cancer cells, especially multicellular clusters, are distinct from their main tumor in various respects to adapt survival advantages during metastasis. Moreover, multicellular …
-
Regulation of Steroid Sulfatase in Human Breast Cancer Cells and Screening of Human Tissues for Steroid Sulfatase Status
Breast cancer is the most frequently occurring cancer in women and is the second leading cause of death. About 40% of breast cancers are hormone-dependent and require estrogen for their growth. The steroid sulfatase pathway is an important means of converting local inactive estrogens to their …
Page 1 of 3